Chitosan does not reduce post-prandial urinary oxalate excretion

Urological Research

Volumn 34, Issue 4, 2006, Pages 227-230

  Wolf, Joshua ^a   Asplin, John R ^b   Goldfarb, David S ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Nephrology Section/111G   (United States)

Author keywords

Chitin analogs and derivatives; Diet; Kidney stones; Polysaccharides; Renal calculi; Urolithiasis

Indexed keywords

CHELATING AGENT; CHITOSAN; OXALIC ACID DERIVATIVE;

ARTICLE; CLINICAL TRIAL; DIET; HUMAN; MALE; URINE;

CHELATING AGENTS; CHITOSAN; DIET; HUMANS; MALE; OXALATES;

EID: 33750604967     PISSN: 03005623     EISSN: 14340879     Source Type: Journal    
DOI: 10.1007/s00240-006-0048-2     Document Type: Article

References (17)

1. Curhan GC (1999) Epidemiologic evidence for the role of oxalate in idiopathic nephrolithiasis. J Endourol 13:629
2. Pak CY, Adams-Huet B, Poindexter JR, Pearle MS, Peterson RD, Moe OW (2004) Rapid communication: relative effect of urinary calcium and oxalate on saturation of calcium oxalate. Kidney Int 66:2032
3. Robertson WG, Hughes H (1993) Importance of mild hyperoxaluria in the pathogenesis of urolithiasis - new evidence from studies in the Arabian peninsula. Scanning Microsc 7:391
4. Pearle MS, Roehrborn CG, Pak CY (1999) Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol 13:679
5. Ni MC, Dunshea-Mooij C, Bennett D, Rodgers A (2005) Chitosan for overweight or obesity. Cochrane Database Syst Rev CD003892
6. Asplin JR, Parks JH, Chen MS, Lieske JC, Toback FG, Pillay SN, Nakagawa Y, Coe FL (1999) Reduced crystallization inhibition by urine from men with nephrolithiasis. Kidney Int 56:1505
7. Jaeger P, Robertson WG (2004) Role of dietary intake and intestinal absorption of oxalate in calcium stone formation. Nephron Physiol 98:64
8. Laminski NA, Meyers AM, Kruger M, Sonnekus MI, Margolius LP (1991) Hyperoxaluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors. Br J Urol 68:454
9. Yagisawa T, Chandhoke PS, Fan J (1999) Comparison of comprehensive and limited metabolic evaluations in the treatment of patients with recurrent calcium urolithiasis. J Urol 161:1449
10. Holmes RP, Goodman HO, Assimos DG (2001) Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 59:270
11. Berg W, Bothor C, Pirlich W, Janitzky V (1986) Influence of magnesium on the absorption and excretion of calcium and oxalate ions. Eur Urol 12:274
12. Hess B, Jost C, Zipperle L, Takkinen R, Jaeger P (1998) High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold normal oxalate load in humans. Nephrol Dial Transplant 13:2241
13. Lindsjo M, Fellstrom B, Ljunghall S, Wikstrom B, Danielson BG (1989) Treatment of enteric hyperoxaluria with calcium-containing organic marine hydrocolloid. Lancet 2:701
14. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346:77
15. Duncan SH, Richardson AJ, Kaul P, Holmes RP, Allison MJ, Stewart CS (2002) Oxalobacter formigenes and its potential role in human health. Appl Environ Microbiol 68:3841
16. Hoppe B, von Unruh UG, Laube N, Hesse A, Sidhu H (2005) Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria? Urol Res 33:372
17. Lieske JC, Goldfarb DS, De Simone C, Regnier C (2005) Use of a probiotic to decrease enteric hyperoxaluria. Kidney Int 68:1244